Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function. B. infantis is the predominant intestinal organism found in breast-fed infants. B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants.
B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species.
Jarro-Dophilus® Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn's immature digestive system.
The Developing Intestinal Microflora of Newborns is up to 90% B. Infantis.
Strains Matter: Jarrow Formula Probiotic contain clinically documented strains
生後6か月までの乳児には、1日1回10滴を食品、ぬるま湯、または粉ミルクに混ぜてご使用ください。または有資格の医療従事者の指示に従ってください。容器をよく振ってからご使用ください。
| サプリメント成分 | ||
| 1回分： 10滴（0.5 ml） | ||
| 内容量： 約30回分 | ||
| 1回当たりの栄養成分 | 1日の摂取量（％） | |
| ビフィドバクテリウム・ロンガム亜種インファンティスM-63 | 生菌10億個（最小値）† | †† |
| †推奨される保存条件の下で使用期限内に摂取した場合、一度の摂取で最小10億個の生菌。 ††1日の摂取量は目安です。 | ||
There are no reviews for this product.